Monday, December 22, 2014 11:35:08 AM
http://cellceutix.com/cellceutix-antibiotic-brilacidin-receives-qidp-designation-from-fda/#sthash.Y1xKjDbV.dpbs
Plus, the FDA also gave the go ahead on a phase II for Prurisol this month:
http://cellceutix.com/cellceutix-prurisol-for-psoriasis-fda-agrees-that-phase-2-study-may-begin/#sthash.uRrUhooP.dpbs
So, I don't believe we lack concrete results.
Edit to add: Follow this link and as time progresses you will see more concrete results:
https://clinicaltrials.gov/ct2/results?term=cellceutix
In Reply to 'maz100577'
The problem is CTIX is not "beyond" releases like the one from this a.m. CTIX IS releases like the one from this a.m. That's who they are, that's what they do. There has never been a PR, ever, with statistical results from a human clinical trial. The sp escalation may make it appear like the company is "beyond" releases like this but releases like this are what drove the share price escalation....sp appreciation doesn't change or legitimize the business operation. The lack of concrete results will be the eventual undoing...it's simply a matter of time...
To follow KarinCA, click here then click "Follow This Member" under my photo.
Be kinder than necessary, for everyone you meet is fighting some kind of battle.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM